Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study.
Charlie B StrangeJoseph TkaczJill SchinkelBenjamin LewingBarnabie AgatepSean SwisherSushma PatelDevechio EdwardsDaniel R TouchetteEdward PortilloNorbert FeiglerMichael PollackPublished in: International journal of chronic obstructive pulmonary disease (2023)
Following a COPD exacerbation, promptly initiating BGF was associated with a reduction in subsequent exacerbations and reduced healthcare utilization and costs.